Sparton Corp (SPA, Financial) files its latest 10-K with SEC for the fiscal year ended on June 30, 2018. Sparton Corp is a provider of design, development, and manufacturing services for complex electromechanical devices and engineered products. The Company serves the medical & biotechnology, military & aerospace and industrial & commercial markets. Sparton Corp has a market cap of $137.210 million; its shares were traded at around $13.95 with and P/S ratio of 0.38. Sparton Corp had annual average EBITDA growth of 7.30% over the past five years.
For the last quarter Sparton Corp reported a revenue of $100.5 million, compared with the revenue of $104.4 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $375.0 million, a decrease of 5.7% from the previous year. For the last five years Sparton Corp had an average revenue growth rate of 6.9% a year.
The reported loss per diluted share was $1.18 for the year, compared with the earnings per share of $-3.91 in the previous year. The Sparton Corp had an operating margin of 1.29%, compared with the operating margin of 1.92% a year before. The 10-year historical median operating margin of Sparton Corp is 4.81%. The profitability rank of the company is 6 (out of 10).
At the end of the fiscal year, Sparton Corp has the cash and cash equivalents of $1.16 million, compared with $0.99 million in the previous year. The long term debt was $84.5 million, compared with $74.7 million in the previous year. Sparton Corp has a financial strength rank of 5 (out of 10).
At the current stock price of $13.95, Sparton Corp is traded at 22.9% discount to its historical median P/S valuation band of $18.10. The P/S ratio of the stock is 0.38, while the historical median P/S ratio is 0.47. The stock lost 39.66% during the past 12 months.
For the complete 20-year historical financial data of SPA, click here.
